Animal model of brain aging: Senescence-accelerated mouse (SAM)

CNS Drug Reviews

Volumn 4, Issue 4, 1998, Pages 361-375

  Miyamoto, Masaomi ^a   Takahashi, Hideki ^a   Ohta, Hiroyuki ^a   Sakamoto, Junko ^a  

^a TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

Author keywords

Anxiety; Behavioral depression; Circadian rhythm; Emotional behavior; Learning and memory; Oxidative stress; SAMP10; SAMP8; Senescence accelerated mouse

Indexed keywords

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; BRAIN FUNCTION; CIRCADIAN RHYTHM; CONTROLLED STUDY; EMOTION; INBRED STRAIN; LEARNING; MEMORY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PASSIVE AVOIDANCE; REVIEW; SENESCENCE; TASK PERFORMANCE;

EID: 0032445560     PISSN: 1080563X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1527-3458.1998.tb00076.x     Document Type: Review

References (71)

1. Abe Y, Yuasa M, Kajiwara Y, et al. Defects of immune cells in the senescence-accelerated mouse: A model for learning and memory deficits in the aged. Cell Immunol 1994;157:59-69.
2. Akiyama H, Kameyama K, Akiguchi I, et al. Periodic acid-Schiff (PAS)-positive, granular structures increase in the brain of senescence-accelerated mouse (SAM). Acta Neuropathol 1986;72:124-129.
3. Beal MF. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol 1995;38:357-366.
4. Butterfield DA, Howard BJ, Yatin S, et al. Free radical oxidation of brain proteins in accelerated senescence and its modulation by N-tert-butyl-α-phenylnitrone. Proc Natl Acad Sci USA 1997;94:674-678.
5. Chen WHM, Hosokawa M, Tsuboyama T, et al. Age-related changes in the temporomandibular joint of the senescence-accelerated mouse (SAM) SAM-P/3 as a new murine model of degenerative joint disease. Am J Pathol 1989;135:379-387.
6. Colwell CS, Kaufman CM, Menaker M. Phase-shifting mechanisms in the mammalian arcadian system: New light on the carbachol paradox. J Neurosci 1993;13:1454-1459.
7. Edamatsu R, Mori A, Packer L. The spin-trap N-tert-α-phenyl-butylnitrone prolongs the life span of the senescence accelerated mouse. Biochem Biophys Res Commun 1995;211:847-849.
8. Flood JF, Merely JE. Early onset of age-related impairment of aversive and appetitive learning in the SAM-P/8 mouse. J Gerontol 1992;47:B52-B59.
9. Flood JF, Morley JE. Age-related changes in footshock avoidance acquisition and retention in senescence accelerated mouse (SAM). Neurobiol Aging 1993;14:153-157.
10. Flood JF, Merely JE, La Reginna M. Age-related changes in the pharmacological involvement of retention in senescence accelerated mouse (SAM). Neurobiol Aging 1993;14:159-166.
11. Fujibayashi Y, Yamamoto S, Waki A, et al. Mitochondrial DNA deletions under conditions of oxidative stress as aging-related abnormalities in the brain of senescence accelerated mouse. Neurosci Lett 1998;254:109-112.
12. Han J, Hosokawa M, Umezawa M, et al. Age-related changes in blood pressure in the senescence-accelerated mouse (SAM): Aged SAMP1 mice manifest hypertensive vascular disease. Lab Anim Sci 1998;48:256-263.
13. Harman D. Free-radical theory of aging: Increasing the functional life span. Ann NY Acad Sci 1994;717:1-15.
14. SAM is an apoA-II apolipoprotein of mouse high density apolipoproteins. J Biol Chem 1986;261:12834-12840.
15. Higuchi K, Kitagawa K, Naiki H, et al. Polymorphism of apolipoprotein A-II (apoA-II) among inbred strains of mice: Relationship between the molecular type of apoA-II and mouse senile amyloidosis. Biochem J 1991;279:427-433.
16. Hosokawa M, Abe T, Higuchi K, et al. Management and design of the maintenance of SAM mouse strains: An animal model for accelerated senescence and age-associated disorders. Exp Gerontol 1997;32:111-116.
17. Hosokawa M, Ashida Y, Tsuboyama T, et al. Cataract in senescence accelerated mouse (SAM). 2. Development of a new strain of mouse with late-appearing cataract. Exp Eye Res 1988;47:629-640.
18. Hosokawa M, Hosono M, Higuchi K, et al. Immune responses in newly developed short-lived SAM mice. I. Age-associated early decline in immune activities of cultured spleen cells. Immunology 1987;625:419-423.
19. Hosokawa M, Hosono M, Hanada K, et al. Immune responses in newly developed short-lived SAM mice. II. Selectivity impaired T-helper cell activity in in vivo antibody response. Immunology 1987;625:424-429.
20. Ida Y, Tanaka M, Kohno Y, et al. Effects of age and stress on regional noradrenaline metabolism in the brain. Neurobiol Aging 1982;3:233-236.
21. Ida Y, Tanaka M, Tsuda A, et al. Attenuating effect of diazepam on stress-induced increases in noradrenaline turnover in specific brain regions of rats. Antagonism by Ro 15-1788. Life Sci 1985;37:2491-2498.
22. Ingram DK, London ED, Reynolds MA. Circadian rhythmicity and sleep: Effects of aging in laboratory animals. Neurobiol Aging 1982;3:287-297.
23. Jilka RL, Weinstein RS, Takahashi K, et al. Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence. J Clin Invest 1996;97:1732-1740.
24. 3H]nitrendipine to cerebral cortical and hippocampal membranes of senescence accelerated mouse. Neurosci Lett 1989;106:334-338.
25. Kurozumi M, Matsushita M, Hosokawa M, et al. Age-related changes in lung structure and function in the senescence-accelerated mouse (SAM): SAM-P/1 as new murine model of senile hyperinflation. Am J Respir Crit Care Med 1994;149:776-782.
26. Markowska A, Spangler EL, Ingram DK. Behavioral assessment of senescence-accelerated mouse (SAMP8 and R1). Physiol Behav 1998;64:15-26.
27. Matsushita M, Tsuboyama R, Kasai R, et al. Age-related changes in bone mass in the senescence-accelerated mouse (SAM). SAM-R/3 and SAM-P/6 as new murine models for senile osteoporosis. Am J Pathol 1996;215:276-283.
28. Meijer JH, Rietveld WJ. The neurophysiology of the suprachiasmatic circadian pacemaker in rodents. Physiol Rev 1989;69:671-708.
29. Mishima K, Okawa M, Hishikawa Y, et al. Morning bright light therapy for sleep and behavior disorders in elderly patients with dementia. Acta Psychiatr Scand 1994;89:1-7.
30. Miyamoto M. Characteristics of memory and behavioral disorders in SAMP8 mice. In: Takeda T, ed. The SAM model of Senescence. Amsterdam: Elsevier, 1994;61-66.
31. Miyamoto M. Characteristics of age-related behavioral changes in senescence-accelerated mouse SAMP8 and SAMP10. Exp Gerontol 1997;32:139-148.
32. Miyamoto M, Kiyota Y, Nishiyama M, Nagaoka A. Senescence-accelerated mouse (SAM): Age-related reduced anxiety-like behavior in the SAM-P/8 strain. Physiol Behav 1992;51:979-985.
33. Miyamoto M, Kiyota Y, Yamazaki N, et al. Age-related changes in learning and memory in the senescence-accelerated mouse (SAM). Physiol Behav 1986;38:399-406.
34. Moriguchi T, Takashina K, Chu P-J, et al. Prolongation of life span and improved learning in the senescence accelerated mouse produced by aged garlic extract. Biol Pharm Bull 1994;17:1589-1594.
35. Nakamura S, Akiguchi I, Seriu N, et al. Monoamine oxidase-B-positive granular structures in the hippocampus of aged senescence-accelerated mouse (SAMP8). Acta Neuropathol 1995;90:626-632.
36. Nishiyama M, Takahashi H, Miyamoto M. Senescence-accelerated mouse (SAMP8): An animal model for age-related circadian rhythm disorder. In: Takeda T, ed. The SAM Model of Senescence. Amsterdam: Elsevier, 1994;393-396.
37. Nishiyama N, Zhou Y, Saito H. Ameliorative effects of chronic treatment using DX9386, a traditional Chinese prescription, on learning performance and lipid peroxide content in senescence accelerated mouse. Biol Pharm Bull 1994;17:1481-1484.
38. Nomura Y, Wang B-X, Qi S-B, et al. Biochemical changes related to aging in the senescence accelerated mouse. Exp Gerontol 1989;24:49-55.
39. Ohta A, Hirano T, Yagi H, et al. Behavioral characteristics of the SAM-P/8 strain in Sidman active avoidance task. Brain Res 1989;498:195-198.
40. Ohta H, Nishikawa H, Hirai K, et al. Relationship of impaired brain glucose metabolism to learning deficit in the senescence-accelerated mouse. Neurosci Lett 1996;217:37-40.
41. Oomura Y, Sasaki K, Li A, et al. Protection against impairment of memory and immunoreactivity in senescence-accelerated mice by acidic fibroblast growth factor. Ann NY Acad Sci 1996;786:337-347.
42. Park J-W, Choi C-H, Kim M-S, Chung M-H. Oxidative stress in senescence-accelerated mice. J Gerontol 1996;51A:B337-B345.
43. Pellow S, Chopin P, File SE, Briley M. Validation of open closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. Neurosci Methods 1985;14:149-165.
44. Pellow S, File SE. Anxiolytic and anxiogenic drug effects in exploratory activity in an elevated plus-maze: A novel test of anxiety in the rat. Pharmacol Biochem Behav 1987;24:525-529.
45. Penev PD, Turk FW, Zee PC. Monoamine depletion alters the entrainment and the response to light of circadian activity rhythm in hamsters. Brain Res 1993;612:156-164.
46. Perry G, Castellani RJ, Hirai K, Smith MA. Reactive oxygen species mediate cellular damage in Alzheimer disease. J Alzheim Dis 1998;1:45-55.
47. Sáchez-Barceló EJ, Magias M, Verduga R, Crespo D. Differences between the circadian rhythm of two strains of senescence-accelerated mice (SAM). Physiol Behav 1997;62:1225-1229.
48. Saitoh Y, Hosokawa M, Shimada A, et al. Age-related hearing impairment in senescence-accelerated mouse (SAM). Hear Res 1994;75:27-37.
49. Saitoh Y, Hosokawa M, Shimada A, et al. Age-related cochlear degeneration in senescence-accelerated mouse. Neurobiol Aging 1995;16:129-136.
50. Sato E, Oda N, Ozaki N, et al. Early and transient increase in oxidative stress in the cerebral cortex of senescence-accelerated mouse. Mech Ageing Dev 1996;86:105-114.
51. Shimada A, Ohta A, Akiguchi I, Takeda T. Inbred SAM-P/10 as a mouse model of spontaneous inherited brain atrophy. J Neuropathol Exp Neurol 1992;51:440-450.
52. Shimada A, Ohta A, Akiguchi I, Takeda T. Age-related deterioration in conditional avoidance task in the SAM-P/10 mouse, an animal model of spontaneous brain atrophy. Brain Res 1993;608:266-272.
53. Smith MA, Perry G, Richey PL, et al. Oxidative stress in Alzheimer's. Nature 1996;382:120-121.
54. Steru L, Chermat R, Thierry B, Simon P. The tail suspension test: A new method for screening antidepressants in mice. Psychopharmacology 1985;85:367-370.
55. Takahashi H, Nishiyama M, Takami K, et al. Effects of chronic administration of idebenone on age-related behavioral disorders in senescence-accelerated mice (SAMP8). In: Takeda T, ed. The SAM model of senescence. Amsterdam: Elsevier, 1994;427-430.
56. Takeda T, Hosokawa M, Higuchi K. Senescence-accelerated mouse (SAM): A novel murine model of accelerated senescence. J Am Geriatr Soc 1991;39:911-919.
57. Takeda T, Hosokawa M, Higuchi K. Senescence-accelerated mouse (SAM): A novel murine model of senescence. Exp Gerontol 1997;32:105-109.
58. Takeda T, Hosokawa M, Higuchi K. Senescence-accelerated mouse (SAM). A novel murine model of aging. In: Takeda T, ed. The SAM model of senescence. Amsterdam: Elsevier, 1994;15-22.
59. Takeda T, Hosokawa M, Takeshita S, et al. A new murine model of accelerated senescence. Mech Ageing Dev 1981;17:183-194.
60. Takeda T, Matsushita T, Kurozumi M, et al. Pathobiology of the senescence-accelerated mouse (SAM). Exp Gerontol 1997;32:117-127.
61. Teramoto S, Fukuchi Y, Uejima X, et al. Age-related changes in GSH content of eyes in mice - A comparison of senescence-accelerated mouse (SAM) and C57BL/J mice. Comp Biochem Physiol 1992;102A:693-696.
62. Van Gool WA, Mirmiran A. Aging and circadian rhythms. Prog Brain Res 1986;70:285-306.
63. Van Someren EJW, Kessler A, Mirmiran M, Swaab DF. Indirect bright light improves circadian rest-activity rhythm disturbances in demented patients. Biol Psychiatry 1997;41:955-963.
64. Van Someren EJW, Mirmiran M, Swaab DF. Non-pharmacological treatment of sleep and wake disturbances in aging and Alzheimer's disease: Chronological perspectives. Behav Brain Res 1993;57:235-253.
65. Vogel JR, Beer B, Clody DE. A simple and reliable conflict procedure for testing antianxiety agents. Psychopharmacologia 1971;4:1-7.
66. Weyer G, Erzigkeit H, Hadler D, Kubicki S. Efficiency and safety of idebenone in the long-term treatment of Alzheimer's disease: A double-blind, placebo controlled multicentre study. Human Psychopharmacol 1996;11:53-65.
67. Yagi H, Akiguchi I, Ohta A, et al. Spontaneous and artificial lesions of magnocellular reticular formation of brainstem deteriorate avoidance learning in senescence-accelerated mouse SAM. Brain Res 1998;791:90-98.
68. Yagi H, Katoh I, Akiguchi I, et al. Age-related deterioration of abnormality of acquisition in memory and learning in senescence accelerated mouse: SAM-P/8 as an animal model of disturbances in recent memory. Brain Res 1988;474:86-93.
69. Yagi H, Irino M, Matsushita M, et al. Spontaneous spongy degeneration of the brainstem in SAM-P/8 mice, a newly developed memory-deficient strain. J Neuropathol Exp Neurol 1989;48:577-590.
70. Zee PC, Rosenberg RS, Turek FW. Effects of aging on entrainment and rate of resynchronization of circadian locomotor activity. Am J Physiol 1992;263:R1099-R1103.
71. 3H]noradrenaline in brain slices of senescence accelerated mouse. Int J Dev Neurosci 1990;8:267-272.